Jefferies Lifts Target on Humana (HUM) Post Q3 Results, Sees 5% MA Margin
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Dow tick higher as investors weigh Mideast negotiations
- Oil falls after US-Iran talks signal easing supply risks
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Analysts Say Humana (HUM) Election Related Selloff Overdone
November 7, 2012 3:28 PM ESTAnalysts at Wedbush said they view today's sell-off in Human (NYSE: HUM) on election and related budget concerns as overdone.
"We believe rate pressure would exist in Medicare regardless of what political party is in power and that 5% margins are sustainable even with... More
Humana, Inc. (HUM) Tops Q3 EPS Views; Boosts FY12 EPS Outlook, Guides FY13
November 5, 2012 6:08 AM ESTHumana, Inc. (NYSE: HUM) reported Q3 EPS of $2.41, $0.36 better than the analyst estimate of $2.05. Revenue for the quarter came in at $0 versus the consensus estimate of $9.86 billion.
Humana, Inc. sees FY2012 EPS of $7.25-7.35, versus the consensus of $7.14.
Humana, Inc. sees... More
